Pharmacogenetic analyses of hematotoxicity in advanced gastric cancer patients receiving biweekly fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): a translational study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).

Goekkurt, E; Al-Batran, S-E; Mogck, U; Pauligk, C; Hartmann, J T; Kramer, M; Jaeger, E; Ehninger, G; Stoehlmacher, J

Goekkurt, E; Al-Batran, S-E; Mogck, U; Pauligk, C; Hartmann, J T; Kramer, M; Jaeger, E; Ehninger, G; Stoehlmacher, J.

Affiliation

Goekkurt E; Department of Internal Medicine I, University Hospital Carl Gustav Carus, University of Dresden, Dresden, Germany.

Ann Oncol ; 20(3): 481-5, 2009 Mar.

Article in En | MEDLINE | ID: mdl-19074750

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Neutropenia/chemically induced; Pharmacogenetics; Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Base Sequence; DNA Primers; DNA Repair; Docetaxel; Fluorouracil/administration & dosage; Humans; Leucovorin/administration & dosage; Organoplatinum Compounds/administration & dosage; Oxaliplatin; Polymerase Chain Reaction; Polymorphism, Genetic; Taxoids/administration & dosage

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmacogenetics / Antineoplastic Combined Chemotherapy Protocols / Neutropenia Type of study: Prognostic_studies Limits: Humans Language: En Journal: Ann Oncol Year: 2009 Document type: Article

Fulltext

XML

PubMed Links

Search on Google